Original Research

Biologic Disease-Modifying and Other Anti-Rheumatic Drugs Use in Patients with Moderate-to-Severe Juvenile Idiopathic Arthritis Based on a Japanese Nationwide Claims Database

Hata T, Hirata A, Ota R, Hosohata K, Nishihara M, Neo M, Katsumata T

Therapeutics and Clinical Risk Management 2022, 18:843-853

Published Date: 24 August 2022